Literature DB >> 8067769

Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy.

J L Gaillard1, V Abadie, G Cheron, F Lacaille, B Mahut, C Silly, V Matha, C Coustere, F Lokiec.   

Abstract

The penetration of ceftriaxone into cerebrospinal fluid (CSF) was studied with 11 children (mean age: 2 years, 4 months; range: 4 months to 8 years) with meningitis, receiving dexamethasone (0.15 mg/kg of body weight intravenously four times daily) as adjunctive therapy. Ceftriaxone was given intravenously at doses of 50 mg/kg twice daily to patients < 18 months old and 100 mg/kg once daily to patients > or = 18 months old. CSF was collected after 1 day of treatment at the expected peak concentration of ceftriaxone in CSF. Concentrations of ceftriaxone in CSF ranged from 0.7 to 9.2 mg/liter, with a mean value of 4.0 (standard deviation [SD], 2.9) mg/liter. Values were significantly higher for patients with CSF glucose levels of < 1 mmol/liter on admission to the hospital than for patients with CSF glucose levels of > or = 1 mmol/liter (mean values of 7.1 [SD, 2.2] mg/liter versus 2.2 [SD, 1.1] mg/liter; P < 0.001). After 1 day of treatment, ceftriaxone concentrations in the CSF of children receiving dexamethasone are similar to the mean values reported for children not treated with dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067769      PMCID: PMC188183          DOI: 10.1128/AAC.38.5.1209

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  The penetration of antibiotics into cerebrospinal fluid and brain tissue.

Authors:  R W Barling; J B Selkon
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

2.  Association between persistence of pneumococcal meningitis and dexamethasone administration.

Authors:  M T Brady; S L Kaplan; L H Taber
Journal:  J Pediatr       Date:  1981-12       Impact factor: 4.406

Review 3.  Penetration of newer cephalosporins into cerebrospinal fluid.

Authors:  C E Cherubin; R H Eng; R Norrby; J Modai; G Humbert; G Overturf
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

4.  Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis.

Authors:  M M Mustafa; O Ramilo; J Mertsola; R C Risser; B Beutler; E J Hansen; G H McCracken
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

Review 5.  Bacterial meningitis: recent advances in pathophysiology and treatment.

Authors:  A R Tunkel; B Wispelwey; W M Scheld
Journal:  Ann Intern Med       Date:  1990-04-15       Impact factor: 25.391

6.  Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.

Authors:  E Martin; J R Koup; U Paravicini; K Stoeckel
Journal:  J Pediatr       Date:  1984-09       Impact factor: 4.406

7.  Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.

Authors:  R Latif; A S Dajani
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

8.  Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children.

Authors:  M A del Rio; D Chrane; S Shelton; G H McCracken; J D Nelson
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

9.  Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis.

Authors:  W M Scheld; J P Brodeur
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

Review 10.  Current management of bacterial meningitis in infants and children.

Authors:  G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1992-02       Impact factor: 2.129

View more
  7 in total

1.  [Not Available].

Authors:  Guillaume Sébire; Claude Cyr
Journal:  Paediatr Child Health       Date:  2006-01       Impact factor: 2.253

2.  Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.

Authors:  I R Friedland; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 3.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis.

Authors:  J L Gaillard; C Silly; A Le Masne; B Mahut; F Lacaille; G Cheron; V Abadie; P Hubert; V Matha; C Coustere
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

6.  Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.

Authors:  K P Klugman; I R Friedland; J S Bradley
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 7.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.